## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-31T11:20:22.038Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "myAllergyPal®" developer_entity: "United Allergy Services" bundle_id: "com.uas.myallergypal" app_store_id: "1256088686" google_play_id: "com.uasmobile" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2025-05-09" report_date: "2026-05-31" last_verified: "2026-05-31" report_version: "1.16" total_reviews: 158 overall_rating: 2.68 sentiment: "Frustrated" sentiment_score: 25 confidence: "low" confidence_score: 0.8 top_praise_theme: "Allergy tracking features provide helpful reminders for medication schedules when the application functions correctly" top_complaint_theme: "Persistent server connectivity errors prevent users from logging injections or accessing their medical data" top_request_theme: "Reliable offline access or local data storage to ensure treatment tracking continues during server outages" review_sample_size: 99 total_review_count: 99 analyzed_review_count: 66 data_age_days: 0 momentum_velocity: "zombie" intelligence_version: 4 competitor_count: 4 tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "patients", "currently", "enrolled"] canonical_url: "https://marlvel.ai/intel-report/medical/myallergypal" license: "CC-BY-NC 4.0" content_version: "v2" --- # myAllergyPal® App Audit ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 2.68 · Sentiment Frustrated - **Recent focus**: Persistent server connectivity errors prevent users from logging injections or accessing their medical data (top complaint) · Allergy tracking features provide helpful reminders for medication schedules when the application functions correctly (top praise) · Reliable offline access or local data storage to ensure treatment tracking continues during server outages (top request) > **TL;DR:** myAllergyPal® is a medical app by United Allergy Services, rated 2.68/5 by 158 users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** myAllergyPal® faces Frustrated user sentiment (2.68/5 from 158 reviews), with persistent server connectivity errors prevent users from logging injections or accessing their medical data as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 2.68/5 (158 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | United Allergy Services | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Low (0.8/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** United Allergy Services - **Category:** Medical - **Target Audience:** Patients currently enrolled in the United Allergy Services immunotherapy protocol and individuals seeking information on allergy testing. - **Platforms:** iOS & Android - **Version Audited:** 1.16 - **Audit Date:** 2026-05-31 - **Signal Count:** 99 reviews analyzed - **Confidence:** Low (0.8/1.0) - **App Store ID (iOS):** 1256088686 - **Bundle ID:** com.uas.myallergypal - **Google Play ID:** com.uasmobile - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-31 ## Executive Snapshot **What it is:** myAllergyPal® is a medical tracking app for United Allergy Services patients, providing immunotherapy dosage logs and pollen forecasts on iOS and Android. **Why users hire it:** Patients hire the app to manage complex immunotherapy schedules, but the current technical failures force them to revert to manual logs, breaking the adherence loop. ## App DNA (Features & Intent) - **[Differentiator] Immunotherapy Dosage Log:** Digital tracking of immunotherapy treatment progress and injection history * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Pollen Forecast:** Four-day localized pollen level and forecast data - **[Standard] Dose Reminders:** Push notifications for scheduled immunotherapy doses and clinic appointments * *User Intent:* Users want timely prompts to stay engaged without missing updates. ## Market Position {#market-position} The app holds a #183 position in the Canadian Medical category, reflecting its niche role as a clinical adherence tool rather than a mass-market health app. ## Monetization Strategy - **Model:** Free - **Tiers:** Free access to all features - **Analysis:** The app operates as a free utility to support the primary business of in-office allergy testing and immunotherapy treatment. ## 🔴 User Sentiment (Low Confidence: 66 of 99 reviews analyzed) {#user-sentiment} - **Overall Rating:** 2.68/5 - **Platform Split:** iOS 2.7/5 (32 ratings) | Android 2.7/5 (126 ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Allergy tracking features provide helpful reminders for medication schedules when the application functions correctly** ### Top Complaints (Impact Areas) - **Persistent server connectivity errors prevent users from logging injections or accessing their medical data** - **Inconsistent notification delivery leads to missed medication doses and potential treatment non-compliance for patients** ### Top Requests (What Users Want) - **Reliable offline access or local data storage to ensure treatment tracking continues during server outages** ## SWOT Analysis {#swot} **Core Strengths:** - Proprietary integration with clinical immunotherapy protocols - Direct B2B distribution channel to existing patients **Critical Frictions:** - 2.7★ rating due to server connectivity failures - High-frequency launch crashes post-update - Lack of offline data logging capability **Growth Levers:** - Implement local data storage for tracking continuity - Add PDF export for clinical progress sharing **Market Threats:** - Manual paper log reversion by patients - Inconsistent notification delivery causing non-compliance - Competitor apps offering superior clinical data export ## Recent Changes (v3 → v4) {#recent-changes} The app's competitive position has declined due to critical technical instability, forcing a shift in roadmap priorities toward server authentication and offline data access. **Overall trend**: Declining **Compared at**: 2026-05-31 ### High-impact changes - **[Declined] Sentiment Score and Outlook** (sentiment) — Sentiment score dropped 50 → 25, and outlook trend shifted from stable → declining due to persistent server connectivity failures. - **[Shifted] Roadmap Priority Pivot** (positioning) — PM action items shifted from PDF export focus to server authentication and local data caching to address connectivity-driven churn. ### Medium-impact changes - **[Added] Technical Weaknesses** (swot) — Added high-frequency launch crashes and lack of offline data logging as primary weaknesses. - **[Declined] Review Volume** (sentiment) — Total review count decreased from 158 → 99. ## What's New - **Latest (v1.16, 1 years ago):** Bug fixes for Dose Reminders. ## App Momentum (Zombie) {#momentum} - Ships stability-focused updates. - Last major release May 2025. > **Cadence:** 2 total versions · 0 majors in last 6 months · 369 days since last update · 0 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} myAllergyPal® is a challenged medical app that is completely free. With a 2.68/5 rating from 158 reviews, it faces significant user friction. > **Bottom Line:** The app fails its primary job of clinical adherence due to persistent server instability, so the PM must prioritize local data caching to ensure patients can log doses regardless of connectivity. **Best for:** Patients currently enrolled in the United Allergy Services immunotherapy protocol and individuals seeking information on allergy testing. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Rebuild server authentication handshake because login failures are the top complaint → restore basic utility — *High-frequency server connectivity errors are the primary driver of negative sentiment.* _(trade-off: deprioritize Pause the pollen forecast UI refresh — server stability has 5× the impact on retention.)_ - [ ] [INVEST] [HIGH IMPACT] Ship local data caching because offline access is the top user request → unlock tracking during outages — *Users report inability to log doses during network outages, forcing manual paper logs.* _(trade-off: deprioritize Deprioritize the Allergen Library content expansion — data integrity is a higher priority than educational content.)_ ### Feature Gaps vs Competitors - PDF clinical report export (available in CBT Thought Diary App but absent here) - Offline-first data logging (available in WorryTree but absent here) ### Outlook: Declining The medical tracking category is shifting toward offline-first reliability, leaving myAllergyPal® exposed due to its dependency on constant server connectivity. Continued failure to stabilize the login process will accelerate patient churn back to manual documentation, effectively nullifying the app's value as a clinical adherence tool. - 🔴 Persistent server connectivity failures post-update erode user trust, forcing patients to revert to manual paper logs for their immunotherapy tracking. - 🔴 Launch crashes following the latest release prevent access to the dosage log, which compounds the existing rating drag on Android. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 2.68/5 | | Total Reviews | 158 | | Sentiment | Frustrated (25/100) | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **myAllergyPal®** (this app) | 2.68/5 | Frustrated | United Allergy Services | | [Poop Tracker- Stool,IBS,Crohns](https://marlvel.ai/intel-report/health-fitness/poop-tracker-stool-ibs-crohns) | 3.9/5 | N/A | CARECLINIC SOFTWARE INC. | | [Be Positive - Be Happier](https://marlvel.ai/intel-report/health-fitness/be-positive-be-happier) | 3.0/5 | N/A | Stanislav Svec | | [CBT Thought Diary App](https://marlvel.ai/intel-report/health-fitness/cbt-thought-diary-app) | 4.9/5 | Thrilled | Aly Bairamov | | [WorryTree: Anxiety Relief](https://marlvel.ai/intel-report/health-fitness/worrytree-anxiety-relief) | 4.6/5 | Excited | WorryTree Ltd | | [Move On with AJ](https://marlvel.ai/intel-report/medical/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd | ## Company Profile - **Developer:** United Allergy Services - **Website:** [https://www.unitedallergyservices.com/myallergypal](https://www.unitedallergyservices.com/myallergypal) - **Social:** [Instagram](https://www.instagram.com/uastagram) · [Facebook](https://www.facebook.com/unitedallergyservices) · [X/Twitter](https://twitter.com/UnitedAllergy) · [LinkedIn](https://www.linkedin.com/company/united-allergy-services) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/myallergypal/id1256088686?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.uasmobile&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.unitedallergyservices.com/myallergypal) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Poop Tracker- Stool,IBS,Crohns*](https://marlvel.ai/intel-report/health-fitness/poop-tracker-stool-ibs-crohns) (CARECLINIC SOFTWARE INC.) — 3.9/5 Rating | N/A Sentiment - [*Be Positive - Be Happier*](https://marlvel.ai/intel-report/health-fitness/be-positive-be-happier) (Stanislav Svec) — 3.0/5 Rating | N/A Sentiment - [*CBT Thought Diary App*](https://marlvel.ai/intel-report/health-fitness/cbt-thought-diary-app) (Aly Bairamov) — 4.9/5 Rating | Excellent Sentiment - [*WorryTree: Anxiety Relief*](https://marlvel.ai/intel-report/health-fitness/worrytree-anxiety-relief) (WorryTree Ltd) — 4.6/5 Rating | Positive Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment - [*Procedure Log*](https://marlvel.ai/intel-report/medical/com-rmk-iosapps-procedure-log) (Robert Kuhnhenn) — 4.8/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.8/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 99 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/myallergypal) Data licensed for AI Agent attribution under CC-BY-NC 4.0.